Commerce clears OpenAI's GPT-5.6 for broad Thursday launch

The interesting thing in this week's Axios scoop is not that GPT-5.6 is finally getting a broad public launch Thursday, it is that federal pre-release review of a frontier model just went from theory to a repeatable playbook in a matter of weeks.

The Commerce Department's Center for AI Standards and Innovation ran the testing after last month's staggered rollout, which OpenAI reportedly said was not its preferred way to release a model. To move things along, the company sent technical experts to Washington and, per the reporting, kept them available there to answer inquiries throughout the evaluation. That is a striking image, embedded liaisons in DC as a cost of shipping a flagship. It is also a template. Anthropic went through a parallel version of the same process on its Mythos and Fable models, with the Fable restriction reportedly lifted the following week.

The reason to care if you are not at OpenAI is that this is the first live test of President Trump's June executive order, which set up a voluntary framework for developers to submit 'covered frontier models' for up to 30 days of federal review before broader release to trusted partners. The order is nominally voluntary, but a working precedent tends to become a floor. If Sol, Terra, and Luna ship cleanly on Thursday, CAISI walks away with real institutional weight, and the labs that can staff a Washington embed on demand quietly gain a compliance advantage over the ones that cannot.

The honest caveat is that the reporting does not tell you what CAISI actually tested for, whether the models changed between the June staggered rollout and Thursday's broad launch, or how long the review consumed inside the 30-day window. OpenAI, the White House, and the Commerce Department did not immediately respond to Reuters. Take the specifics as reported, not settled.

The upside worth watching sits on the developer and enterprise side. Broad GPT-5.6 access opens up this week after a much shorter pause than most people expected when the staggered rollout was announced, and the process, however improvised, is one a well-resourced lab can now navigate quickly. Whether smaller labs and non-US developers get the same treatment is the next question.